These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29359834)

  • 21. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
    El-Helaly M; Khan W; El-Saed A; Balkhy HH
    J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers.
    Park JH; Kim N; Park H; Kim TS; Park SW; Roh EY; Yoon JH; Shin S
    PLoS One; 2020; 15(6):e0235254. PubMed ID: 32603343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cascade of care in testing and treatment of latent tuberculosis infection in liver transplant candidates.
    Foppiano Palacios C; Medvedeva N; Cheung H; Cohen E; Azar MM; Malinis M
    Transpl Infect Dis; 2023 Feb; 25(1):e13999. PubMed ID: 36484433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demographics and prevalence of positive QuantiFERON-TB Gold In-Tube test in renal transplant candidates.
    Simkins J; Kraus K; Morris MI
    Transpl Infect Dis; 2016 Feb; 18(1):5-13. PubMed ID: 26534762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Rates of Indeterminate TB Tests Among Hospitalized Patients: Can We Optimize Use of Gamma Interferon Release Assays in Tuberculosis?
    Bouton TC; Gillani FS; Lu S; Carter EJ
    R I Med J (2013); 2019 Aug; 102(6):27-30. PubMed ID: 31398965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review.
    Roth PJ; Grim SA; Gallitano S; Adams W; Clark NM; Layden JE
    Transpl Infect Dis; 2016 Feb; 18(1):14-21. PubMed ID: 26671024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and management of latent tuberculosis in liver transplant patients.
    Jafri SM; Singal AG; Kaul D; Fontana RJ
    Liver Transpl; 2011 Mar; 17(3):306-14. PubMed ID: 21384513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-gamma release assay for screening of tuberculosis infection in children.
    Zheng H; Xiao J; Li F; Chen H; Li D; Wang Y; Guo Y; Chen Y; Shen C
    BMC Infect Dis; 2023 Dec; 23(1):873. PubMed ID: 38093183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
    Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indeterminate QuantiFERON®-TB Gold results in a public health clinic setting.
    Banach DB; Harris TG
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1623-30. PubMed ID: 22118169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis.
    Zhou G; Luo Q; Luo S; Chen H; Cai S; Guo X; He J; Xia Y; Li H; Zhou Y; Zhang Y; Song C
    Front Immunol; 2023; 14():1170579. PubMed ID: 37256138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
    Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay.
    Shu CC; Hsu CL; Wei YF; Lee CY; Liou HH; Wu VC; Yang FJ; Lin HH; Wang JY; Chen JS; Yu CJ; Lee LN
    Medicine (Baltimore); 2016 May; 95(22):e3813. PubMed ID: 27258523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.